Trial intelligence / Profile preview

Ciprofol vs dexmedetomidine for perioperative delirium in elderly hip fracture surgery

ChiCTR2200066225Phase 4Recruiting

Sponsor
Beijing Jishuitan Hospital
Start
Dec 2022
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ciprofol and dexmedetomidine in perioperative neurocognitive disorder and delirium (2 arms), sponsored by Beijing Jishuitan Hospital. Primary endpoint: Incidence of delirium. Started Dec 2022; status: recruiting.

02

Drugs

ciprofoldexmedetomidine
03

Conditions

perioperative neurocognitive disorderdelirium

Beyond the preview

Go deeper on ChiCTR2200066225.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200066225.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call